tumor related depression
Conditions
Interventions
placebo group:placebo
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) in line with the cancer diagnostic criteria of the international anticancer Federation, patients with malignant tumors diagnosed by pathology and / or cytology; (2) patients who were diagnosed with depressive symptoms according to Hamilton Depression Rating Scale (HAMD17); (3) TCM syndrome differentiation is consistent with the guiding principles of clinical research on new drugs in 2002, and TCM syndrome types include liver depression and spleen deficiency syndrome; (4) aged 18-80 years; (5) the KPS score was more than 60; (6) the life period is expected to be >3 months; (7) no radiochemotherapy, glucocorticoid and other antidepressant treatments were carried out in the past 1 months; (8) voluntarily take part in the clinical research and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) combined with severe heart, liver and kidney dysfunction and hematopoietic diseases; (2) illiteracy, mental retardation or psychosis; (3) women in pregnancy and lactation; (4) other clinical trials are being accepted; (5) the research data are incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HAMD17;FLIC;TESS; | — |
Secondary
| Measure | Time frame |
|---|---|
| HAMA;T Cell Subsets; | — |
Countries
China
Contacts
Public ContactTian Xin
Outcome results
None listed